CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 41 filers reported holding CTI BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,169,668 | +12.3% | 1,026,567 | +8.7% | 0.02% | +6.2% |
| Q3 2022 | $5,495,000 | -8.1% | 944,113 | -5.7% | 0.02% | -5.9% |
| Q2 2022 | $5,977,000 | +35.7% | 1,001,113 | +6.1% | 0.02% | +41.7% |
| Q1 2022 | $4,406,000 | +218.4% | 943,413 | +69.0% | 0.01% | +300.0% |
| Q4 2021 | $1,384,000 | -56.6% | 558,113 | -48.4% | 0.00% | -62.5% |
| Q3 2021 | $3,191,000 | +8.9% | 1,081,613 | -7.7% | 0.01% | 0.0% |
| Q2 2021 | $2,931,000 | +93.6% | 1,172,213 | +125.3% | 0.01% | +100.0% |
| Q1 2021 | $1,514,000 | +321.7% | 520,213 | +366.1% | 0.00% | +300.0% |
| Q4 2020 | $359,000 | -24.7% | 111,613 | -49.7% | 0.00% | 0.0% |
| Q3 2020 | $477,000 | +345.8% | 221,983 | +141.6% | 0.00% | – |
| Q2 2020 | $107,000 | +25.9% | 91,883 | -1.1% | 0.00% | – |
| Q1 2020 | $85,000 | -42.6% | 92,883 | -0.9% | 0.00% | – |
| Q4 2019 | $148,000 | +57.4% | 93,683 | -16.8% | 0.00% | – |
| Q3 2019 | $94,000 | -3.1% | 112,583 | -0.5% | 0.00% | – |
| Q2 2019 | $97,000 | -12.6% | 113,183 | -1.1% | 0.00% | – |
| Q1 2019 | $111,000 | +30.6% | 114,483 | -0.9% | 0.00% | – |
| Q4 2018 | $85,000 | -61.2% | 115,483 | +14.0% | 0.00% | -100.0% |
| Q3 2018 | $219,000 | -54.6% | 101,283 | +4.5% | 0.00% | 0.0% |
| Q2 2018 | $482,000 | – | 96,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|